ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Artificial Skin Dressing With pH-Switchable Nanozyme Activity for Bidirectional ROS Regulation in Infected Diabetic Wound Management.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Diabetic infected wounds heal poorly due to the synergistic effects of hyperglycemia, persistent microbial colonization, and chronic inflammation. We developed a pH-switchable artificial skin dressing TPI-PADL, to address these challenges. This system adapts to changes in the wound microenvironment over time. The dressing incorporates polydopamine and L-arginine modified PtAu nanozymes into a conductive ionogel-fiber scaffold. In the acidic and hyperglycemic conditions of early infection, the nanozymes exhibit glucose oxidase-like and cascade catalytic activities, increasing reactive oxygen species (ROS) production. The elevated ROS levels effectively kill bacteria and disrupt biofilms. As the wound environment shifts toward neutral pH, the nanozyme activity changes. The system begins to scavenge excess ROS and generate oxygen. The released oxygen reduces oxidative stress and improves local oxygen supply. These changes promote angiogenesis and guide macrophages toward a pro-healing phenotype. In vitro and in vivo evaluations confirm that TPI-PADL coordinates antibacterial, anti-inflammatory, antioxidant, and pro-regenerative effects. The ionogel network provides strain-sensing capability. This feature enables real-time monitoring of mechanical changes during healing. This strategy integrates therapy and sensing in a single platform for diabetic wound management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.